相关实验视频
Updated: Jul 9, 2025

03:22
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
730
埃托里科克西布诱导的肺部溢液:一个病例报告
Bishal Kumar Sah1, Ravi Ranjan Pradhan2, Sangam Shah3
1Institute of Medicine Tribhuvan University Maharajgunj Nepal.
Clinical case reports
|November 29, 2023
概括
药物诱导的胸腔溢出是一种罕见的疾病. 这一案例突出了非类固醇抗炎药物埃托利克西布作为潜在的原因,强调了排除诊断.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肺部病理学 肺部病理学
- 内部医学 内部医学
背景情况:
- 药物诱导的胸腔溢出是一种罕见的临床诊断.
- 非类固醇抗炎药物 (NSAIDs) 广泛用于治疗疼痛和炎症.
- 作为一种选择性COX-2抑制剂的 etoricoxib 已知与传统的NSAID相比,其胃肠道副作用较少.
相关概念视频
Pleural Effusion I: Introduction
1.1K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.1K
Pleural Effusion II: Symptoms and Management
183
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
183
Esophageal Perforation-II: Clinical Manifestations and Management
65
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
65
Pneumothorax-II
160
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
160
Pneumothorax-I
216
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
216
Pleural Disorders: Types and Brief Description
211
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
211

